• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep . ARAP2 regulates responses to interferon-gamma by restricting SOCS1

tetano

Editor, Senior Moderator
Cell Rep


. 2025 Dec 15;44(12):116667.
doi: 10.1016/j.celrep.2025.116667. Online ahead of print. ARAP2 regulates responses to interferon-gamma by restricting SOCS1

Narelle Keating[SUP] 1 [/SUP], Karen Doggett[SUP] 1 [/SUP], Grace M Bidgood[SUP] 1 [/SUP], Lizeth G Meza Guzman[SUP] 1 [/SUP], Laura F Dagley[SUP] 1 [/SUP], Kunlun Li[SUP] 1 [/SUP], Bailey E Williams[SUP] 1 [/SUP], Anna Gabrielyan[SUP] 1 [/SUP], Carolina Alvarado[SUP] 1 [/SUP], Benjamin J Broomfield[SUP] 1 [/SUP], Brigette C Duckworth[SUP] 1 [/SUP], Colin Hockings[SUP] 1 [/SUP], Jumana Yousef[SUP] 1 [/SUP], Evelyn Leong[SUP] 1 [/SUP], Rhiannon Morris[SUP] 1 [/SUP], Andrew Kueh[SUP] 2 [/SUP], Alexandra L Garnham[SUP] 1 [/SUP], Göknur Giner[SUP] 1 [/SUP], Jean-Laurent Casanova[SUP] 3 [/SUP], Stephanie Boisson-Dupuis[SUP] 4 [/SUP], Jeffrey J Babon[SUP] 1 [/SUP], Edmond M Linossi[SUP] 5 [/SUP], Michelle D Tate[SUP] 6 [/SUP], Joanna R Groom[SUP] 1 [/SUP], Sandra E Nicholson[SUP] 7 [/SUP]



Affiliations
Abstract

Interferon-gamma (IFNγ) is critical for immunity against intra-macrophagic pathogens, signaling through the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway to induce a tyrosine-phosphorylation cascade that ensures a potent immune response. Excessive JAK-STAT signaling can drive hyperinflammation and autoimmunity; thus, signaling is tightly and selectively regulated by the IFNγ-inducible protein, suppressor of cytokine signaling 1 (SOCS1). SOCS1 inhibits signaling by directly blocking JAK kinase activity. Here, we identified a SOCS1-interacting partner, ankyrin repeat and pleckstrin homology domain 2 (ARAP2), that fine-tunes SOCS1 function. We report that tyrosine 415 in ARAP2 binds the SOCS1-Src homology 2 (SH2) domain and limits the ability of SOCS1 to inhibit IFNγ signaling. Our findings show that ARAP2 promotes the IFNγ response through a phosphorylation-dependent interaction with the negative regulator SOCS1, and this exacerbates inflammation in a mouse model of influenza virus infection.

Keywords: ARAP2; CP: immunology; IFNγ; JAK; SH2 domain; SOCS1; STAT; influenza; interferon; tyrosine.

 
Back
Top